Scienture Holdings (SCNX) EBIT Margin (2013 - 2026)
Scienture Holdings' (SCNX) quarterly EBIT Margin came in at 785.63% in Q2 2026, up 87.39% quarter-over-quarter from 6230.8% in Q1 2026.
Powered by 
Analysis
Scienture Holdings (SCNX) EBIT Margin (2013 - 2026) Analysis & Trends
Scienture Holdings has disclosed EBIT Margin across 14 years of filings, most recently posting 785.63% for Q2 2026.
- In Q2 2026, EBIT Margin changed N/A year-over-year to 785.63%; the TTM figure through Jun 2026 stood at 3641.55% (down 398876.0% YoY), while the FY2025 annual figure was 9867.92%, up 89078.0% from the prior year.
- EBIT Margin came in at 785.63% for Q2 2026 at Scienture Holdings, up from 6230.8% in the prior quarter.
- In the past five years, EBIT Margin ranged from a high of 73.0% in Q4 2023 to a low of 34814.94% in Q1 2025.
- Average EBIT Margin over 5 years is 4189.49%, with a median of 118.91% recorded in 2022.
- Year-over-year, EBIT Margin plunged 783514 bps in 2024 and surged 2858414 bps in 2026.
- Over 5 years, EBIT Margin stood at 74.41% in 2022, then jumped by 198 bps to 73.0% in 2023, then sank by 11057 bps to 7998.78% in 2024, then sank by 335 bps to 34814.94% in 2025, then soared by 98 bps to 785.63% in 2026.
- Per Business Quant data, the three most recent EBIT Margin figures were 785.63% in Q2 2026, 6230.8% in Q1 2026, and 34814.94% in Q1 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 42.34 Bn | 38.68 Bn | 2.15 Bn | -5.58% |
| 2 | Viatris | 19.39 Bn | 18.50 Bn | 1.46 Bn | 0.17% |
| 3 | Dr Reddys Laboratories | 9.99 Bn | 9.85 Bn | 396.53 Mn | 4.69% |
| 4 | Amneal Pharmaceuticals | 5.57 Bn | 5.53 Bn | 334.51 Mn | 16.30% |
| 5 | Bausch Health Companies | 2.45 Bn | 1.58 Bn | 2.10 Bn | 25.95% |
| 6 | Ani Pharmaceuticals | 1.70 Bn | 1.34 Bn | 165.89 Mn | 15.21% |
| 7 | Alvotech | 1.66 Bn | 1.52 Bn | 2.56 Mn | -134.08% |
| 8 | Amphastar Pharmaceuticals | 985.90 Mn | 695.77 Mn | 93.47 Mn | 21.60% |
| 9 | Fennec Pharmaceuticals | 434.07 Mn | 392.82 Mn | 17.15 Mn | 9.72% |
| 10 | Scienture Holdings | 15.19 Mn | 15.19 Mn | 335,779.00 | -785.63% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -785.63% |
| Mar 31, 2026 | -6,230.80% |
| Mar 31, 2025 | -34,814.94% |
| Jun 30, 2024 | -7,998.78% |
| Dec 31, 2023 | 73.00% |
| Sep 30, 2023 | -41.07% |
| Jun 30, 2023 | -163.64% |
| Mar 31, 2023 | -163.40% |
| Dec 31, 2022 | -74.41% |
| Sep 30, 2022 | -10.64% |
| Jun 30, 2022 | -33.64% |
| Mar 31, 2022 | -29.89% |
| Dec 31, 2021 | -32.76% |
| Sep 30, 2021 | -50.83% |
| Jun 30, 2021 | -135.37% |
| Mar 31, 2021 | -21.10% |
| Dec 31, 2020 | -115.60% |
| Sep 30, 2020 | 2.30% |
| Jun 30, 2020 | -8.12% |
| Mar 31, 2020 | 8.54% |